The_DT
tumor_NN
associated_JJ
cell_NN
surface_NN
antigen_NN
A6H_NN
is_VBZ
costimulatory_JJ
for_IN
human_JJ
CD4_NN
+_NN
but_CC
not_RB
CD8_NN
+_CC
T_NN
cells_NNS
._.

The_DT
A6H_NN
monoclonal_JJ
antibody_NN
-LRB-_-LRB-
mAb_NN
-RRB-_-RRB-
recognizes_VBZ
a_DT
120,000-140_NN
,000_CD
MW_NN
antigen_NN
that_WDT
is_VBZ
expressed_VBN
at_IN
similar_JJ
densities_NNS
on_IN
85-90_CD
%_NN
of_IN
human_JJ
CD4_NN
+_NN
and_CC
CD8_NN
+_CC
T_NN
cells_NNS
and_CC
on_IN
renal_JJ
cell_NN
carcinomas_NNS
._.

The_DT
binding_NN
of_IN
the_DT
A6H_NN
mAb_NN
induced_VBD
a_DT
costimulatory_JJ
signal_NN
in_IN
anti-CD3_JJ
activated_VBN
T_NN
cells_NNS
._.

In_IN
the_DT
present_JJ
report_NN
,_,
we_PRP
show_VBP
that_IN
A6H_NN
costimulated_VBD
cell_NN
proliferation_NN
and_CC
cytokine_NN
production_NN
in_IN
purified_VBN
CD4_NN
+_CC
T_NN
cells_NNS
._.

Unexpectedly_RB
,_,
the_DT
CD8_NN
+_CC
T-cell_NN
subpopulation_NN
failed_VBD
to_TO
respond_VB
._.

CD4_NN
+_CC
T_NN
cells_NNS
costimulated_VBN
with_IN
the_DT
A6H_NN
mAb_NN
upregulated_VBD
CD80_NN
,_,
CD86_NN
,_,
CD71_NN
,_,
interleukin-2_NN
-LRB-_-LRB-
IL-2_NN
-RRB-_-RRB-
R_NN
alpha_NN
,_,
IL-2R_NN
beta_NN
and_CC
IL-2R_NN
gamma_NN
,_,
while_IN
no_DT
corresponding_JJ
up-regulation_NN
of_IN
these_DT
cell_NN
surface_NN
molecules_NNS
was_VBD
seen_VBN
in_IN
CD8_NN
+_CC
T_NN
cells_NNS
._.

In_IN
order_NN
to_TO
investigate_VB
the_DT
nature_NN
of_IN
the_DT
A6H_NN
mAb_NN
costimulus_NN
at_IN
the_DT
transcriptional_JJ
level_NN
we_PRP
have_VBP
examined_VBN
induction_NN
of_IN
the_DT
transcription_NN
factors_NNS
OCT-1_NN
,_,
AP-1_NN
and_CC
NF-kappa_NN
B_NN
which_WDT
are_VBP
known_VBN
to_TO
be_VB
transcriptional_JJ
regulators_NNS
of_IN
several_JJ
cytokine_NN
and_CC
cytokine_NN
receptor_NN
genes_NNS
,_,
including_VBG
the_DT
IL-2_NN
and_CC
IL-2R_NN
genes_NNS
._.

Co-ligation_NN
of_IN
the_DT
A6H_NN
antigen_NN
and_CC
the_DT
CD3_NN
complex_NN
induced_VBD
expression_NN
of_IN
the_DT
transcription_NN
factor_NN
AP-1_NN
in_IN
CD4_NN
+_CC
T_NN
cells_NNS
,_,
whereas_IN
no_DT
increase_NN
in_IN
NF-kappa_NN
B_NN
and_CC
octamer-binding_JJ
-LRB-_-LRB-
Oct_NN
-RRB-_-RRB-
proteins_NNS
was_VBD
seen_VBN
compared_VBN
to_TO
T_NN
cells_NNS
stimulated_VBN
with_IN
anti-CD3_NN
alone_RB
._.

Furthermore_RB
,_,
no_DT
induction_NN
of_IN
AP-1_NN
was_VBD
seen_VBN
in_IN
A6H_NN
costimulated_NN
CD8_NN
+_CC
T_NN
cells_NNS
._.

These_DT
results_NNS
suggests_VBZ
that_IN
both_CC
proximal_JJ
steps_NNS
in_IN
CD8_NN
+_CC
T-cell_NN
activation_NN
as_RB
well_RB
as_IN
the_DT
later_JJ
phases_NNS
are_VBP
unresponsive_JJ
to_TO
A6H_NN
ligation_NN
._.

Molecular_JJ
differences_NNS
of_IN
the_DT
A6H_NN
molecule_NN
or_CC
distinct_JJ
regulation_NN
of_IN
the_DT
A6H_NN
transduced_NN
AP-1_NN
activation_NN
pathway_NN
may_MD
exist_VB
in_IN
CD4_NN
+_NN
and_CC
CD8_NN
+_CC
T_NN
cell_NN
subpopulations_NNS
._.

